Net Cash Provided by (Used in) Financing Activities in USD of Intra-Cellular Therapies, Inc. from Q2 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q2 2013 to 2024.
  • Intra-Cellular Therapies, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $9.99M, a 174% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $568M, a 3086% increase from 2023.
  • Intra-Cellular Therapies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $17.8M, a 96.1% decline from 2022.
  • Intra-Cellular Therapies, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $455M, a 3851% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Intra-Cellular Therapies, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $9.99M +$6.35M +174% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $3.64M -$438M -99.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $442M +$440M +30753% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $1.43M -$276M -99.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $278M +$278M +888514% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $31.2K -$307K -90.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $338K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q2 2013 $5.9K* Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-15

Intra-Cellular Therapies, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $568M +$550M +3086% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 $17.8M -$437M -96.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 $455M +$444M +3851% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-21
2021 $11.5M -$653M -98.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $664M +$661M +20427% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $3.24M +$2.55M +372% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $685K -$162M -99.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $162M +$162M +33885% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $478K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.